Your browser doesn't support javascript.
loading
Endogenous α7 nAChR Agonist SLURP1 Facilitates Escherichia coli K1 Crossing the Blood-Brain Barrier.
He, Xiaolong; Wang, Lei; Liu, Liqun; Gao, Jie; Long, Beiguo; Chi, Feng; Hu, Tongtong; Wan, Yu; Gong, Zelong; Li, Li; Zhen, Peilin; Zhang, Tiesong; Cao, Hong; Huang, Sheng-He.
Afiliación
  • He X; Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
  • Wang L; Department of Infectious Disease, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-Sen University, Jiangmen, China.
  • Liu L; Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
  • Gao J; Saban Research Institute, University of Southern California, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Long B; Department of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Chi F; Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
  • Hu T; Department of Infectious Disease, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-Sen University, Jiangmen, China.
  • Wan Y; Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
  • Gong Z; Saban Research Institute, University of Southern California, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Li L; Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
  • Zhen P; Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
  • Zhang T; Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
  • Cao H; Saban Research Institute, University of Southern California, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Huang SH; Kunming Key Laboratory of Children Infection and Immunity, Yunnan Institute of Pediatrics, Kunming Children's Hospital, Kunming, China.
Front Immunol ; 12: 745854, 2021.
Article en En | MEDLINE | ID: mdl-34721415
ABSTRACT
Alpha 7 nicotinic acetylcholine receptor (α7 nAChR) is critical for the pathogenesis of Escherichia coli (E. coli) K1 meningitis, a severe central nervous system infection of the neonates. However, little is known about how E. coli K1 manipulates α7 nAChR signaling. Here, through employing immortalized cell lines, animal models, and human transcriptional analysis, we showed that E. coli K1 infection triggers releasing of secreted Ly6/Plaur domain containing 1 (SLURP1), an endogenous α7 nAChR ligand. Exogenous supplement of SLURP1, combined with SLURP1 knockdown or overexpression cell lines, showed that SLURP1 is required for E. coli K1 invasion and neutrophils migrating across the blood-brain barrier (BBB). Furthermore, we found that SLURP1 is required for E. coli K1-induced α7 nAChR activation. Finally, the promoting effects of SLURP1 on the pathogenesis of E. coli K1 meningitis was significantly abolished in the α7 nAChR knockout mice. These results reveal that E. coli K1 exploits SLURP1 to activate α7 nAChR and facilitate its pathogenesis, and blocking SLURP1-α7 nAChR interaction might represent a novel therapeutic strategy for E. coli K1 meningitis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Barrera Hematoencefálica / Activador de Plasminógeno de Tipo Uroquinasa / Antígenos Ly / Meningitis por Escherichia coli / Escherichia coli / Infecciones por Escherichia coli / Receptor Nicotínico de Acetilcolina alfa 7 Límite: Animals / Humans / Newborn Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Barrera Hematoencefálica / Activador de Plasminógeno de Tipo Uroquinasa / Antígenos Ly / Meningitis por Escherichia coli / Escherichia coli / Infecciones por Escherichia coli / Receptor Nicotínico de Acetilcolina alfa 7 Límite: Animals / Humans / Newborn Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China